roflumilast
arcutis biotherapeutics,astrazeneca
['roflumilast', 'psoriasis', 'derm', 'arcutis']
arcutis biotherapeutics, inc. will present 4 abstracts for its topical #roflumilast program in seborrheic #dermatitis and #psoriasis at the 31st european academy of dermatology and venereology (eadv) congress in milan, italy. #eadvcongress 
Dermatology Times: The latest news and trends in dermatologic procedures, therapy, technology, products and drugs.